Osimertinib Resistance and EGFR Mutations in NSCLC Treatment
The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. This mutation ...
The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. This mutation ...
Lung cancer is one of the most common types of cancer worldwide, and the treatment process for patients with non-small ...
Team identifies crucial interaction between platelets and tumors for the first timeCredit: Texas A&M Engineering In the evolving field of ...
Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tractCredit: UAB BIRMINGHAM, Ala. - There ...
MUSC Hollings Cancer Center part of promising clinical trial for aggressive lymphomaCredit: MUSC Hollings Emma C. Vought MUSC Hollings Cancer ...
Credit: Trinity College Dublin. Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, July 21, 2021-- Evaluating the efficacy of novel therapies requires the ...
Researchers first to model COVID-19 completion vs. cessation study using machine learningCredit: Florida Atlantic University/College of Engineering and Computer Science ...
FDA approval based on positive results of international, multi-center ProDERM studyCredit: Octapharma PARAMUS, N.J. - The U.S. Food and Drug ...
Researchers find clues about how molecule improves appearance of scarsCredit: (Gourdie Lab /Virginia Tech) Surgical scars treated with a molecule ...
These findings suggest that for therapies to be effective, they must be targeted at both gene productsCredit: CNIO KRAS was ...
Credit: WFIRM WINSTON-SALEM, NC, JULY 19, 2021 -- Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, July 14, 2021-Firsthand reports from nurses in correctional facilities detail the ...
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.